Bristol-Myers Squibb announces Retirement of Brian Daniels
Posted: 7 May 2014 | | No comments yet
Bristol-Myers Squibb Company announced that Brian Daniels, senior vice president, Global Development and Medical Affairs, will be retiring from the company…
Bristol-Myers Squibb Company (NYSE:BMY) today announced that Brian Daniels, senior vice president, Global Development and Medical Affairs, will be retiring from the company, effective July 1, 2014.
Dr. Daniels joined Bristol-Myers Squibb in 2000 and has held his current position as senior vice president, Global Development and Medical Affairs since 2008, leading the development of numerous innovative medicines such as Eliquis and Yervoy that address serious diseases and communicating the value of these medicines to society to ensure their safe and appropriate use.
“Brian has played a key leadership role in the success of the company’s R&D organization and our ability to deliver innovative medicines to patients with serious diseases,” said Francis Cuss, executive vice president and chief scientific officer, Bristol-Myers Squibb. “He has been a champion of the patients we serve, and I want to sincerely thank him for his loyalty and dedication to Bristol-Myers Squibb.”
